We are live on ! Find out more
HSTO

Histogen Inc. Common Stock

Delisted

HSTO was delisted on the 4th of October, 2023.

48 hedge funds and large institutions have $52M invested in Histogen Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 6

56% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 9

37% more capital invested

Capital invested by funds: $37.8M → $52M (+$14.2M)

33% more funds holding

Funds holding: 3648 (+12)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
48
Holders Change
+12
Holders Change %
+33.33%
% of All Funds
1.39%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
18
Increased
14
Reduced
9
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
VAM
51
Visium Asset Management
New York
-$370K -287 Closed
SIM
52
Spark Investment Management
New York
-$67K -53 Closed
SO
53
STRS Ohio
Ohio
-$25.1K -12 Closed
Wells Fargo
54
Wells Fargo
California
-$14.6K -7 Closed

HSTO Hedge Fund Activity: Q1 2014 in Review

48 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q1 2014, worth a combined $52M — up 37% from $37.8M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new HSTO positions and 6 closed out — a net gain of 12 holders — while 14 added to existing stakes and 9 trimmed.

The largest buyer was Axa, opening a new position worth an estimated $3.06M. The largest seller was Polar Capital, cutting an estimated $2.85M.

  • 48 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q1 2014, up from 36 in Q4 2013.
  • Funds reported $52M of Histogen Inc. Common Stock stock for Q1 2014, up 37% quarter-over-quarter.
  • 18 funds opened new Histogen Inc. Common Stock positions in Q1 2014 and 6 closed out, a net change of +12 holders.
  • The largest Histogen Inc. Common Stock buyer in Q1 2014 was Axa, an estimated $3.06M added.
  • The largest Histogen Inc. Common Stock seller in Q1 2014 was Polar Capital, an estimated $2.85M sold.

Based on aggregated 13F filings for Q1 2014.